Supernus Pharmaceuticals Inc Financial Flexibility Index
Supernus Pharmaceuticals Inc financial flexibility index. Supernus Pharmaceuticals Inc (SUPN) has a Financial Flexibility Index of -0.01x as of June 2026. Free cash flow of $-4.24 Million (operating CF $-4.81 Million minus capex $568.00K) represents 0% of total liabilities ($396.88 Million). Explore SUPN capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Supernus Pharmaceuticals Inc (2008–2025)
Financial flexibility index of Supernus Pharmaceuticals Inc from 2008 to 2025. Historical Financial Flexibility Index trend for Supernus Pharmaceuticals Inc across 18 annual periods. Check Supernus Pharmaceuticals Inc (SUPN) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Supernus Pharmaceuticals Inc Financial Flexibility Index by Year (2008–2025)
Supernus Pharmaceuticals Inc financial flexibility index by year from 2008 to 2025. Year-by-year free cash flow to debt coverage for Supernus Pharmaceuticals Inc. For the full cash flow conversion analysis, see cash flow conversion of Supernus Pharmaceuticals Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.12x | $48.67 Million | $47.33 Million | $390.93 Million | ▼ -76.0% |
| 2024 | 0.52x | $172.68 Million | $171.95 Million | $332.34 Million | ▲ +65.8% |
| 2023 | 0.31x | $111.64 Million | $111.08 Million | $356.16 Million | ▲ +118.2% |
| 2022 | 0.14x | $117.24 Million | $116.83 Million | $816.30 Million | ▼ -2.9% |
| 2021 | 0.15x | $129.17 Million | $127.13 Million | $873.30 Million | ▼ -20.8% |
| 2020 | 0.19x | $141.85 Million | $138.40 Million | $759.24 Million | ▼ -27.7% |
| 2019 | 0.26x | $145.87 Million | $143.13 Million | $564.85 Million | ▲ +4.4% |
| 2018 | 0.25x | $129.83 Million | $128.99 Million | $524.79 Million | ▼ -66.7% |
| 2017 | 0.74x | $116.67 Million | $114.64 Million | $156.98 Million | ▲ +28.0% |
| 2016 | 0.58x | $68.42 Million | $66.81 Million | $117.81 Million | ▲ +18.5% |
| 2015 | 0.49x | $34.23 Million | $32.12 Million | $69.86 Million | ▲ +289.3% |
| 2014 | 0.13x | $8.33 Million | $7.73 Million | $66.15 Million | ▲ +117.6% |
| 2013 | -0.72x | $-55.60 Million | $-57.95 Million | $77.53 Million | ▲ +43.8% |
| 2012 | -1.28x | $-46.45 Million | $-47.20 Million | $36.42 Million | ▼ -59.1% |
| 2011 | -0.80x | $-35.50 Million | $-36.19 Million | $44.29 Million | ▼ -127.0% |
| 2010 | -0.35x | $-32.25 Million | $-32.54 Million | $91.33 Million | ▼ -1007.6% |
| 2009 | 0.04x | $3.35 Million | $2.63 Million | $86.06 Million | ▲ +111.1% |
| 2008 | -0.35x | $-29.52 Million | $-29.65 Million | $83.88 Million | — |